Please assess the completion status of the following clinical trial:

Trial Title: Long Term Immunogenicity Study of Engerix-B Vaccine in 10 Year Old Children and the Effect of Booster Injections

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Previously completed the 1995 to 1996 Hepatitis B vaccination program vaccinations (Primary study) to the best of his/her knowledge and already enrolled and followed in the long term study~* Must be HBc negative~* Required standard interval between last dose of primary immunization and booster vaccination~* Written informed consent obtained from the subject~* Free of obvious health problems as established by medical history and clinical examination before entering into the study~* Previously completed routine childhood vaccination to the best of his/her knowledge~* If the subject is female, and the potential of pregnancy exists, it must be asked prior to immunization by the study nurse. According to the protocol d'immunisation du Québec, Engerix-B is not contra-indicated during pregnancy. However, if a participant thinks she could be pregnant (sexually active and no oral contraception or intra uterine device), a pregnancy test will be carried out. In case of pregnancy, the booster vaccination will be performed after delivery.~Exclusion Criteria:~- Not applicable

- Gender: ALL
- Minimum Age: 8 Years
- Maximum Age: 10 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).